{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:28:03Z","timestamp":1793399283063,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1996,1,1]],"date-time":"1996-01-01T00:00:00Z","timestamp":820454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathology"],"published-print":{"date-parts":[[1996]]},"DOI":"10.1080\/00313029600169813","type":"journal-article","created":{"date-parts":[[2005,10,6]],"date-time":"2005-10-06T22:21:40Z","timestamp":1128637300000},"page":"167-172","source":"Crossref","is-referenced-by-count":11,"title":["An evaluation of the in vitro activity of piperacillin\/tazobactam"],"prefix":"10.1016","volume":"28","author":[{"given":"D.","family":"Daley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mulgrave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Munro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Neville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Dimech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1080\/00313029600169813_bib1420","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/jac\/12.5.507","article-title":"Plasmid determined beta-lactamases identified in a group of 204 ampicillin-resistant Enterobacteriaceae","volume":"12","author":"Roy","year":"1983","journal-title":"J Antimicrob Chemother"},{"key":"10.1080\/00313029600169813_bib1425","series-title":"Beta-lactamases: current perspectives","first-page":"31","article-title":"Plasmid-mediated beta-lactamases: relative clinical importance","author":"Aymes","year":"1988"},{"key":"10.1080\/00313029600169813_bib1430","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/clind\/15.5.824","article-title":"Beta-lactam resistance in Gram negative bacteria: global trends and clinical impact","volume":"15","author":"Sanders","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1080\/00313029600169813_bib1435","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF01641355","article-title":"Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens","volume":"11","author":"Knothe","year":"1983","journal-title":"Infection"},{"key":"10.1080\/00313029600169813_bib1440","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1128\/AAC.32.9.1365","article-title":"Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: rote of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffnsion tests","volume":"32","author":"Semders","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1080\/00313029600169813_bib1445","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1128\/AAC.34.4.622","article-title":"Beta lactamase production in members of the family Enterobacteriacae and resistance to beta-lactam-enzyme inhibitor combinations","volume":"34","author":"Thomson","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl B","key":"10.1080\/00313029600169813_bib1450","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/18.Supplement_B.31","article-title":"Genetic and biochemical basis of resistance of Enterobacteriaceae to beta-lactam antibiotics","volume":"18","author":"Wiedemann","year":"1986","journal-title":"J Antimicrob Chemotber"},{"key":"10.1080\/00313029600169813_bib1455","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/clinids\/10.4.830","article-title":"Inducible beta-lactamases: clinical and epidemioIogical implications for use of newer cephalosporins","volume":"10","author":"Sanders","year":"1988","journal-title":"Rev Infect Dis"},{"key":"10.1080\/00313029600169813_bib1460","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1128\/AAC.29.5.955","article-title":"Comparative evaluation of a new beta-lactmnase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harbouring known beta-lactamases","volume":"29","author":"Gutman","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1080\/00313029600169813_bib1465","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0732-8893(89)90082-5","article-title":"Comparative in vitro activity of piperacillin combined with the beta-lactamase inhibitor tazobactam (YTR 830)","volume":"12","author":"Eliopoulos","year":"1989","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1080\/00313029600169813_bib1470","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1128\/AAC.33.8.1268","article-title":"Comparative in vitro activities of piperacillintazobactam and ticarcillin-clavulanate","volume":"33","author":"Fass","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1080\/00313029600169813_bib1475","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1128\/AAC.30.5.789","article-title":"Comparative activity of beta-lactamase inhibitor YTR 830, clavulanate and sulbactam combined with beta-lactams against beta-lactamase-producing anaerobes","volume":"30","author":"Appelbaum","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1080\/00313029600169813_bib1480","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1128\/JCM.27.4.731-734.1989","article-title":"Identification of Enterococcus species isolated from human infections by a conventional test scheme","volume":"27","author":"Facklam","year":"1989","journal-title":"J Clin Microbiol"},{"key":"10.1080\/00313029600169813_bib1485","unstructured":"National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically M7-A3. NCCLS Villanova, PA, 1993"},{"key":"10.1080\/00313029600169813_bib1490","unstructured":"National Committee for Clinical Laboratory Standards: Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria Mll-A3. NCCLS, Villanova, PA, 1983"},{"key":"10.1080\/00313029600169813_bib1495","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5694\/j.1326-5377.1989.tb136365.x","article-title":"A national survey of antibiotic resistance in Staphylococcus aureus in Australian hospitals","volume":"150","author":"Tumidge","year":"1989","journal-title":"Med J Aust"},{"key":"10.1080\/00313029600169813_bib1500","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1128\/JCM.29.1.109-114.1991","article-title":"Quantitative antimicrobial susceptibility testing of Haemophilus influenzae and Streptococcus pneumoniae using the E test","volume":"29","author":"Jorgensen","year":"1991","journal-title":"J Clin Microbiol"},{"key":"10.1080\/00313029600169813_bib1505","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/jac\/27.6.749","article-title":"Activity of clavulanate combinations against TEM-1 beta-lactamase producing Escherichia coli isolates obtained in 1982 and 1989","volume":"27","author":"Seetulsingh","year":"1991","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl","key":"10.1080\/00313029600169813_bib1510","doi-asserted-by":"crossref","first-page":"S562","DOI":"10.1093\/clinids\/8.Supplement_5.S562","article-title":"Induction\/inhibition of chromosomal beta-lactamases by beta-lactamase inhibitors","volume":"8","author":"Moosedeen","year":"1986","journal-title":"Rev Infect Dis"},{"key":"10.1080\/00313029600169813_bib1515","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/AAC.36.4.783","article-title":"Overproduction of a penicillin-binding protein is the only mechanism of penicillin resistance in Enterococcusfaecium","volume":"36","author":"Klare","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1080\/00313029600169813_bib1520","series-title":"Monograph published by Merck Sharp and Dohme","article-title":"Foreword: Resistance in Intensive Care Units 1990","author":"Tnmidge","year":"1992"},{"key":"10.1080\/00313029600169813_bib1525","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1128\/AAC.38.3.494","article-title":"Effect of hyper production of TEM-1 beta-lactamase on in vitro susceptibility of E. coli to beta lactam antibiotics","volume":"38","author":"Wu","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1080\/00313029600169813_bib1530","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/CMR.8.4.557","article-title":"Beta-lactamases in laboratory and clinical resistance","volume":"8","author":"Livermore","year":"1995","journal-title":"Clin Micro Rev"},{"key":"10.1080\/00313029600169813_bib1535","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1445-5994.1988.tb00193.x","article-title":"Infection in neutropaenic patients","volume":"18","author":"Rawlinson","year":"1988","journal-title":"Aust NZ J Med"},{"key":"10.1080\/00313029600169813_bib1540","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1128\/AAC.36.12.2766","article-title":"Piperacillin-tazobactam versus imipenem for treatment o:f intra-abdominal infections","volume":"36","author":"Brismar","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl A","key":"10.1080\/00313029600169813_bib1545","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/jac\/31.suppl_A.87","article-title":"and Study Group. Efficacy, safety and tolerance of parenteral piperacillin\/tazobactam in the treatment of patients with lower respiratory tract infections","volume":"31","author":"Mouton","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1080\/00313029600169813_bib1550","series-title":"ICAAC","first-page":"647","article-title":"Randomised trial of piperacillin\/tazobactam plus amikacin versus ceftazidime plus amikacin in 222 febrile neutropenic patients","author":"Marie","year":"1993"},{"issue":"Suppl A","key":"10.1080\/00313029600169813_bib1555","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jac\/31.suppl_A.113","article-title":"Safety profile of piperacillin\/tazobactam in phase I and phase ItI clinical studies","volume":"31","author":"Kuye","year":"1993","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl A","key":"10.1080\/00313029600169813_bib1560","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/jac\/31.suppl_A.9","article-title":"Determinants of the activity of beta-lactamase inhibitor combinalions","volume":"31","author":"Livermore","year":"1993","journal-title":"J Antimicrob Chemother"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003130251635187X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003130251635187X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T05:48:03Z","timestamp":1586497683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003130251635187X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1996]]}},"alternative-id":["S003130251635187X"],"URL":"https:\/\/doi.org\/10.1080\/00313029600169813","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[1996]]}}}